Get started
Author

Minjie Zhang

Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
2022 · Antoine Simoneau, Justin L. Engel, et al. · Molecular Cancer Therapeutics · 86
VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
2022 · Julie A. Shields, Samuel R. Meier, et al. · Cancer Research · 62
PDF
Chronic Sleep Deprivation Impairs Visual Functions via Oxidative Damage in Mice
2024 · Liying Tang, Houjian Zhang, et al. · American Journal Of Pathology · 21
PDF
Insights into the compact CRISPR–Cas9d system
2025 · Jie Yang, Tongyao Wang, et al. · Nature Communications · 16
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy
2025 · Leanne G. Ahronian, Soumyadip Sahu, et al. · Cancer Research · 14
PDF
MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
2025 · Xiaochun Zhang, Dana C. Borcherding, et al. · Clinical Cancer Research · 12
PDF
Targeting KRAS in colorectal cancer (Review)
2025 · Minjie Zhang, Dawei Wu, et al. · Molecular and Clinical Oncology · 9
PDF
Ribosome biogenesis controls cranial suture MSC fate via the complement pathway in mouse and human iPSC models
2023 · Supawadee Jariyasakulroj, Wei Zhang, et al. · Stem Cell Reports · 9
High expression of PDCD11 in colorectal cancer and its correlation with the prognosis and immune cell infiltration
2024 · Xiongfeng Li, Gaowa Sharen, et al. · Heliyon · 5
TNG961 Is a Selective Oral HBS1L Molecular Glue Degrader for the Treatment of FOCAD- Deleted Cancers
2026 · Hilary E. Nicholson, Douglas A. Whittington, et al. · Cancer Discovery · 3
Cell depleted areas do not repopulate after diphtheria toxin-induced killing of mandibular cartilage chondrocytes
2021 · Y. He, M. Zhang, et al. · Osteoarthritis and Cartilage · 3
PDF
Lactylation in urological malignancies: emerging mechanisms and therapeutic direction
2026 · Jiafeng Lin, Chenye Yuan, et al. · Frontiers in Cell and Developmental Biology · 2
PDF
NaRu-3 ameliorates experimental rheumatoid arthritis via MAPK pathway inhibition
2026 · Lingfeng Ma, Chao Yu, et al. · Journal of Ethnopharmacology · 1
Abstract B027: TNG961: A selective oral molecular glue degrader of HBS1L inducing tumor regression in naïve and PRMT5i-refractory FOCAD-deleted models
2025 · Katherine Lazarides, Minjie Zhang, et al. · Molecular Cancer Therapeutics · 1
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor
2025 · Scott Throner, Tianshu Feng, et al. · Bioorganic & Medicinal Chemistry Letters · 1
Supplementary Tables from Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
2023 · Antoine Simoneau, Justin L. Engel, et al. · 1
Supplementary Data from Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
2023 · Antoine Simoneau, Justin L. Engel, et al. · 1
451 Targeting IL-18BP-mediated adaptive resistance with WB01 restores endogenous IL-18 activity and enhances checkpoint inhibitor efficacy
2026 · Minjie Zhang, Goran Rakocevic, et al. · Journal for ImmunoTherapy of Cancer
PDF
Supplementary Figure S2 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S5 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S6 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Figure S6 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S8 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S7 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Supplementary Table S4 from TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
2026 · Alvin Ziying Lu, Brian B. Haines, et al.
Works count: 106
Citation count: 247
H-index: 8
I10-index: 6
Year
Topic
Type